Danish company finds potential weight-loss drug

NEW YORK Good results from a study of a new drug from Denmark-based NeuroSearch caused the company’s stock to increase the most in more than a month, according to Bloomberg.

Studies of the experimental drug tesofensine showed that it improved fat metabolism and lowered weight. The results caused NeuroSearch’s stock to rise by about $2.20 to $50.77, a 4.5 percent increase.

The drug company said it hoped to find a partner to fund the testing required to gain regulatory approval for the drug, which could generate $1.1 billion in sales if approved.

One dollar equaled 5 kroner, as of mid-day Tuesday.